Published
2026-01-28
Issue
Section
Pharmacy Practice & Practice-Based Research
Categories
License
Copyright (c) 2026 Emily Ditari Sika, Olanrewaju Olamide Popoola, Virginia Giolito, Zainab Galadima Abubakar, Stephen Chubiyojo
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright of content published in INNOVATIONS in pharmacy belongs to the author(s).
A cross-sectional evaluation of advanced pharmacy practice and specialisation among hospital pharmacists in a Nigerian tertiary health Institution: trends, barriers and recommendations
Emily Ditari Sika
International Pharmaceutical Federation Early Career Pharmaceutical Group (FIP ECPG)
https://orcid.org/0009-0009-3846-8155
Olanrewaju Olamide Popoola
Queen Margaret University
https://orcid.org/0000-0002-8384-879X
Virginia Giolito
Pole of Pharmacology and Therapeutics (FATH) Institut de Recherche Expérimentale et Clinique (IREC), University of Louvain (UCL)
https://orcid.org/0000-0002-4888-7857
Zainab Galadima Abubakar
University of Abuja Teaching Hospital
Stephen Chubiyojo
University of Abuja Teaching Hospital
DOI: https://doi.org/10.24926/iip.v16i4.6907
Keywords: pharmacists, advanced pharmacy practice, specialisation, hospital pharmacy, Nigeria, challenges, recommendations
Abstract
Introduction: Hospital pharmacy has evolved to include advanced roles such as medication therapy management, pharmacogenomics, and collaborative prescribing. Advanced pharmacy practice and specialisation (APPS) plays a crucial role in improving healthcare access, reducing costs, enhancing the quality of care, and achieving better patient outcomes. This study assessed the extent of APP and specialisation at the University of Abuja Teaching Hospital (UATH), identified key challenges, and proposed recommendations for improving APP in Nigeria
Method: This cross-sectional, mixed-methods study collected quantitative data through a self-administered online questionnaire, while qualitative data was collected through five interviews. Data were analysed using SPSS (v23) and inductive thematic analysis. Census sampling was employed, and ethical approval was granted by the UATH Ethical Review Board (UATH/HREC/PR/2024/0/9192).
Results: Of the 48 respondents, 79% expressed interest in specialisation, although only 37% had commenced residency training and 44% held advanced certifications. Engagement in advanced pharmacy practice was limited to 50%, and pharmacists lacked prescribing rights. Interest in specialisation was significantly influenced by qualification, with B.Pharm/M.Pharm holders showing greater interest (p=0.014). Younger pharmacists expressed less interest in pursuing specialization. Motivations for pursuing specialisation included career advancement (54%), personal interest (50%), and improved patient care (40%). Qualitative data revealed that limited financial support, insufficient institutional support, and professional barriers such as the absence of a structured specialisation pathway, limited recognition of APP, and limited interprofessional collaboration were major obstacles.
Conclusion: Improving access to funding for specialisation training, implementing supportive policies such as the consultancy cadre, and increasing awareness and education on the value of APP are essential towards its wider adoption in Nigeria.
Downloads
Author Biography
Virginia Giolito, Pole of Pharmacology and Therapeutics (FATH) Institut de Recherche Expérimentale et Clinique (IREC), University of Louvain (UCL)
She has two affiliations:
- Pole of Pharmacology and Therapeutics (FATH) Institut de Recherche Expérimentale et Clinique (IREC), University of Louvain (UCL)
- International Pharmaceutical Federation (FIP)
